Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hippocampus | 20 | 2025 | 817 | 3.670 |
Why?
|
| Place Cells | 6 | 2022 | 18 | 3.300 |
Why?
|
| Neurons | 14 | 2025 | 2009 | 1.810 |
Why?
|
| Visual Cortex | 4 | 2021 | 126 | 1.620 |
Why?
|
| Action Potentials | 10 | 2025 | 467 | 1.570 |
Why?
|
| Wakefulness | 5 | 2024 | 104 | 1.560 |
Why?
|
| Social Learning | 2 | 2025 | 9 | 1.430 |
Why?
|
| Spatial Memory | 4 | 2022 | 29 | 1.270 |
Why?
|
| Sleep | 3 | 2024 | 374 | 1.010 |
Why?
|
| Rats | 14 | 2025 | 3459 | 1.000 |
Why?
|
| Behavior, Animal | 6 | 2025 | 502 | 0.920 |
Why?
|
| Memory Consolidation | 1 | 2024 | 12 | 0.860 |
Why?
|
| Gyrus Cinguli | 1 | 2025 | 134 | 0.830 |
Why?
|
| CA1 Region, Hippocampal | 4 | 2021 | 71 | 0.780 |
Why?
|
| Grid Cells | 1 | 2022 | 3 | 0.780 |
Why?
|
| Spatial Behavior | 2 | 2015 | 12 | 0.750 |
Why?
|
| Lysergic Acid Diethylamide | 1 | 2021 | 8 | 0.710 |
Why?
|
| Rats, Long-Evans | 6 | 2025 | 98 | 0.680 |
Why?
|
| Animals | 28 | 2025 | 34288 | 0.590 |
Why?
|
| Rett Syndrome | 2 | 2018 | 229 | 0.570 |
Why?
|
| Disease Models, Animal | 5 | 2018 | 4692 | 0.510 |
Why?
|
| Observation | 1 | 2016 | 39 | 0.500 |
Why?
|
| Memory Disorders | 1 | 2018 | 207 | 0.490 |
Why?
|
| Mental Recall | 1 | 2017 | 142 | 0.480 |
Why?
|
| Interneurons | 3 | 2022 | 147 | 0.470 |
Why?
|
| Fear | 1 | 2017 | 195 | 0.460 |
Why?
|
| Maze Learning | 3 | 2025 | 99 | 0.430 |
Why?
|
| Sleep Stages | 1 | 2014 | 31 | 0.430 |
Why?
|
| Tauopathies | 1 | 2015 | 71 | 0.430 |
Why?
|
| Theta Rhythm | 3 | 2025 | 24 | 0.400 |
Why?
|
| Receptors, Nicotinic | 4 | 2002 | 121 | 0.400 |
Why?
|
| Models, Animal | 2 | 2013 | 460 | 0.380 |
Why?
|
| Memory, Short-Term | 2 | 2025 | 143 | 0.380 |
Why?
|
| Pyramidal Cells | 3 | 2016 | 151 | 0.340 |
Why?
|
| Memory | 3 | 2018 | 360 | 0.330 |
Why?
|
| Neurodegenerative Diseases | 1 | 2013 | 290 | 0.310 |
Why?
|
| Neuronal Plasticity | 3 | 2018 | 298 | 0.300 |
Why?
|
| Spatial Learning | 2 | 2021 | 15 | 0.290 |
Why?
|
| Disease Progression | 1 | 2015 | 2230 | 0.290 |
Why?
|
| Nerve Net | 2 | 2025 | 271 | 0.280 |
Why?
|
| Nonlinear Dynamics | 1 | 2008 | 57 | 0.280 |
Why?
|
| Neural Inhibition | 2 | 2016 | 111 | 0.270 |
Why?
|
| Models, Neurological | 3 | 2025 | 208 | 0.250 |
Why?
|
| Learning | 2 | 2022 | 378 | 0.250 |
Why?
|
| Electromyography | 2 | 2021 | 141 | 0.230 |
Why?
|
| Entorhinal Cortex | 2 | 2022 | 23 | 0.220 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2018 | 284 | 0.220 |
Why?
|
| Long-Term Potentiation | 2 | 2022 | 105 | 0.210 |
Why?
|
| Acetylcholine | 2 | 2001 | 77 | 0.210 |
Why?
|
| Mice, Transgenic | 4 | 2025 | 2367 | 0.200 |
Why?
|
| Orientation | 1 | 2022 | 39 | 0.190 |
Why?
|
| Male | 12 | 2025 | 65464 | 0.190 |
Why?
|
| Brain Waves | 1 | 2023 | 43 | 0.190 |
Why?
|
| Space Perception | 1 | 2022 | 53 | 0.190 |
Why?
|
| Mice | 10 | 2025 | 18397 | 0.190 |
Why?
|
| Reward | 2 | 2021 | 117 | 0.180 |
Why?
|
| Fluorobenzenes | 1 | 2021 | 39 | 0.170 |
Why?
|
| Synapses | 2 | 2022 | 452 | 0.170 |
Why?
|
| Piperidines | 1 | 2021 | 232 | 0.150 |
Why?
|
| tau Proteins | 2 | 2025 | 252 | 0.130 |
Why?
|
| Fornix, Brain | 1 | 2016 | 23 | 0.120 |
Why?
|
| Avoidance Learning | 1 | 2017 | 63 | 0.120 |
Why?
|
| Electric Stimulation | 1 | 2017 | 249 | 0.120 |
Why?
|
| Temporal Lobe | 1 | 2016 | 116 | 0.120 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 97 | 0.110 |
Why?
|
| Spatial Navigation | 1 | 2014 | 20 | 0.110 |
Why?
|
| Amyloidosis | 1 | 2014 | 70 | 0.100 |
Why?
|
| Periodicity | 2 | 2023 | 49 | 0.090 |
Why?
|
| Neural Pathways | 1 | 2014 | 289 | 0.090 |
Why?
|
| Algorithms | 1 | 2018 | 1690 | 0.090 |
Why?
|
| Mecamylamine | 2 | 2001 | 8 | 0.090 |
Why?
|
| Nicotinic Antagonists | 2 | 2001 | 8 | 0.080 |
Why?
|
| Bicuculline | 2 | 2001 | 17 | 0.080 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 449 | 0.080 |
Why?
|
| Nicotine | 2 | 2002 | 119 | 0.080 |
Why?
|
| Mice, Knockout | 1 | 2018 | 3864 | 0.080 |
Why?
|
| Patch-Clamp Techniques | 2 | 2001 | 279 | 0.080 |
Why?
|
| Phenotype | 2 | 2018 | 4550 | 0.080 |
Why?
|
| In Vitro Techniques | 2 | 2001 | 817 | 0.080 |
Why?
|
| Female | 7 | 2018 | 71430 | 0.070 |
Why?
|
| Exploratory Behavior | 1 | 2008 | 53 | 0.070 |
Why?
|
| Task Performance and Analysis | 1 | 2008 | 83 | 0.070 |
Why?
|
| Cell Count | 1 | 2006 | 217 | 0.060 |
Why?
|
| Probability | 1 | 2006 | 310 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2006 | 244 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 4734 | 0.060 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 2 | 2002 | 53 | 0.050 |
Why?
|
| Amino Acid Substitution | 2 | 2002 | 410 | 0.050 |
Why?
|
| Ganglionic Stimulants | 1 | 2002 | 7 | 0.050 |
Why?
|
| Heterozygote | 2 | 2002 | 728 | 0.050 |
Why?
|
| Electroencephalography | 1 | 2006 | 875 | 0.040 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 2001 | 14 | 0.040 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2001 | 15 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2001 | 366 | 0.040 |
Why?
|
| Tobacco Use Disorder | 1 | 2001 | 90 | 0.040 |
Why?
|
| Aconitine | 1 | 2000 | 8 | 0.040 |
Why?
|
| GABA Antagonists | 1 | 2000 | 17 | 0.040 |
Why?
|
| Tetrodotoxin | 1 | 2000 | 48 | 0.040 |
Why?
|
| Alzheimer Disease | 2 | 2014 | 878 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2001 | 297 | 0.040 |
Why?
|
| Receptors, GABA-A | 1 | 2000 | 60 | 0.040 |
Why?
|
| Point Mutation | 1 | 2001 | 339 | 0.040 |
Why?
|
| Dopamine | 1 | 2001 | 256 | 0.040 |
Why?
|
| Humans | 5 | 2024 | 132158 | 0.040 |
Why?
|
| Silicon | 1 | 2018 | 13 | 0.040 |
Why?
|
| Computer Graphics | 1 | 2018 | 40 | 0.040 |
Why?
|
| Synaptic Transmission | 1 | 2000 | 329 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 1146 | 0.030 |
Why?
|
| Perforant Pathway | 1 | 2016 | 9 | 0.030 |
Why?
|
| Seizures | 1 | 2002 | 892 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2016 | 100 | 0.030 |
Why?
|
| Gene Duplication | 1 | 2016 | 364 | 0.030 |
Why?
|
| Mosaicism | 1 | 2016 | 252 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2014 | 174 | 0.030 |
Why?
|
| Environment | 1 | 2014 | 149 | 0.020 |
Why?
|
| Homeostasis | 1 | 2016 | 715 | 0.020 |
Why?
|
| Brain | 1 | 2023 | 3253 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 6288 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 6206 | 0.010 |
Why?
|
| Dihydro-beta-Erythroidine | 1 | 2002 | 3 | 0.010 |
Why?
|
| Neuroanatomy | 1 | 2002 | 11 | 0.010 |
Why?
|
| Threonine | 1 | 2002 | 62 | 0.010 |
Why?
|
| Limbic System | 1 | 2001 | 22 | 0.010 |
Why?
|
| Nicotinic Agonists | 1 | 2001 | 33 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2002 | 251 | 0.010 |
Why?
|
| Lysine | 1 | 2002 | 165 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2001 | 467 | 0.010 |
Why?
|